These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20350124)

  • 1. Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020.
    Huang RS; Dolan ME
    Pharmacogenomics; 2010 Apr; 11(4):471-4. PubMed ID: 20350124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copy number polymorphisms and anticancer pharmacogenomics.
    Gamazon ER; Huang RS; Dolan ME; Cox NJ
    Genome Biol; 2011; 12(5):R46. PubMed ID: 21609475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics and pharmacogenomics of anticancer agents.
    Huang RS; Ratain MJ
    CA Cancer J Clin; 2009; 59(1):42-55. PubMed ID: 19147868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomic discovery approaches: will the real genes please stand up?
    Walgren RA; Meucci MA; McLeod HL
    J Clin Oncol; 2005 Oct; 23(29):7342-9. PubMed ID: 16145062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using pharmacogene polymorphism panels to detect germline pharmacodynamic markers in oncology.
    Hertz DL; McLeod HL
    Clin Cancer Res; 2014 May; 20(10):2530-40. PubMed ID: 24831276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer.
    Sauna ZE; Kimchi-Sarfaty C; Ambudkar SV; Gottesman MM
    Cancer Res; 2007 Oct; 67(20):9609-12. PubMed ID: 17942888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics of Chemotherapy-Induced Cardiotoxicity.
    Chang VY; Wang JJ
    Curr Oncol Rep; 2018 Apr; 20(7):52. PubMed ID: 29713898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances and challenges in hereditary cancer pharmacogenetics.
    Cascorbi I; Werk AN
    Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):73-82. PubMed ID: 27603572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics in the cancer clinic: from candidate gene studies to next-generation sequencing.
    Guchelaar HJ; Gelderblom H; van der Straaten T; Schellens JH; Swen JJ
    Clin Pharmacol Ther; 2014 Apr; 95(4):383-5. PubMed ID: 24448475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future prospects for pharmacogenetics in the quest for personalized medicine.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Dec; 50(12):13-6. PubMed ID: 23457712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical translation of cell-based pharmacogenomic discovery.
    Cox NJ; Gamazon ER; Wheeler HE; Dolan ME
    Clin Pharmacol Ther; 2012 Oct; 92(4):425-7. PubMed ID: 22910437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics of sex difference in chemotherapeutic toxicity.
    Wang J; Huang Y
    Curr Drug Discov Technol; 2007 Jun; 4(1):59-68. PubMed ID: 17630929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman RA
    Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics and cancer stem cells: a changing landscape?
    Crea F; Duhagon MA; Farrar WL; Danesi R
    Trends Pharmacol Sci; 2011 Aug; 32(8):487-94. PubMed ID: 21529973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomic biomarkers for personalized cancer treatment.
    Rodríguez-Antona C; Taron M
    J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in the development and use of pharmacogenomic markers in oncology.
    Innocenti F
    J Support Oncol; 2007 Jan; 5(1):15-6. PubMed ID: 17265781
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of single-nucleotide polymorphism maps in pharmacogenomics.
    McCarthy JJ; Hilfiker R
    Nat Biotechnol; 2000 May; 18(5):505-8. PubMed ID: 10802616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman R
    Biotechniques; 2005 Oct; 39(10 Suppl):S565-8. PubMed ID: 18957038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer pharmacogenomics: strategies and challenges.
    Wheeler HE; Maitland ML; Dolan ME; Cox NJ; Ratain MJ
    Nat Rev Genet; 2013 Jan; 14(1):23-34. PubMed ID: 23183705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in pharmacogenomic research and development.
    McCarthy JJ
    Mol Biotechnol; 2003 Nov; 25(3):275-82. PubMed ID: 14668540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.